105 related articles for article (PubMed ID: 25565311)
1. No development of hypertension in the hyperuricemic liver-Glut9 knockout mouse.
Preitner F; Pimentel A; Metref S; Berthonneche C; Sarre A; Moret C; Rotman S; Centeno G; Firsov D; Thorens B
Kidney Int; 2015 May; 87(5):940-7. PubMed ID: 25565311
[TBL] [Abstract][Full Text] [Related]
2. Urate-induced acute renal failure and chronic inflammation in liver-specific Glut9 knockout mice.
Preitner F; Laverriere-Loss A; Metref S; Da Costa A; Moret C; Rotman S; Bazin D; Daudon M; Sandt C; Dessombz A; Thorens B
Am J Physiol Renal Physiol; 2013 Sep; 305(5):F786-95. PubMed ID: 23804456
[TBL] [Abstract][Full Text] [Related]
3. Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders.
Lu J; Hou X; Yuan X; Cui L; Liu Z; Li X; Ma L; Cheng X; Xin Y; Wang C; Zhang K; Wang X; Ren W; Sun R; Jia Z; Tian Z; Mi QS; Li C
Kidney Int; 2018 Jan; 93(1):69-80. PubMed ID: 28729031
[TBL] [Abstract][Full Text] [Related]
4. SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney.
Auberson M; Stadelmann S; Stoudmann C; Seuwen K; Koesters R; Thorens B; Bonny O
Pflugers Arch; 2018 Dec; 470(12):1739-1751. PubMed ID: 30105595
[TBL] [Abstract][Full Text] [Related]
5. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy.
Preitner F; Bonny O; Laverrière A; Rotman S; Firsov D; Da Costa A; Metref S; Thorens B
Proc Natl Acad Sci U S A; 2009 Sep; 106(36):15501-6. PubMed ID: 19706426
[TBL] [Abstract][Full Text] [Related]
6. Identification of GLUT12/SLC2A12 as a urate transporter that regulates the blood urate level in hyperuricemia model mice.
Toyoda Y; Takada T; Miyata H; Matsuo H; Kassai H; Nakao K; Nakatochi M; Kawamura Y; Shimizu S; Shinomiya N; Ichida K; Hosoyamada M; Aiba A; Suzuki H
Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18175-18177. PubMed ID: 32690690
[TBL] [Abstract][Full Text] [Related]
7. Total saponins from Discorea nipponica ameliorate urate excretion in hyperuricemic mice.
Zhou Q; Yu DH; Zhang C; Liu SM; Lu F
Planta Med; 2014 Oct; 80(15):1259-68. PubMed ID: 25248048
[TBL] [Abstract][Full Text] [Related]
8. Wuling san ameliorates urate under-excretion and renal dysfunction in hyperuricemic mice.
Ding XQ; Pan Y; Wang X; Ma YX; Kong LD
Chin J Nat Med; 2013 May; 11(3):214-21. PubMed ID: 23725832
[TBL] [Abstract][Full Text] [Related]
9. The effect of testosterone upon the urate reabsorptive transport system in mouse kidney.
Hosoyamada M; Takiue Y; Shibasaki T; Saito H
Nucleosides Nucleotides Nucleic Acids; 2010 Jul; 29(7):574-9. PubMed ID: 20589576
[TBL] [Abstract][Full Text] [Related]
10. Pallidifloside D, a saponin glycoside constituent from Smilax riparia, resist to hyperuricemia based on URAT1 and GLUT9 in hyperuricemic mice.
Wu XH; Ruan JL; Zhang J; Wang SQ; Zhang YW
J Ethnopharmacol; 2014 Nov; 157():201-5. PubMed ID: 25267580
[TBL] [Abstract][Full Text] [Related]
11. Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9.
DeBosch BJ; Kluth O; Fujiwara H; Schürmann A; Moley K
Nat Commun; 2014 Aug; 5():4642. PubMed ID: 25100214
[TBL] [Abstract][Full Text] [Related]
12. Mouse GLUT9: evidences for a urate uniporter.
Bibert S; Hess SK; Firsov D; Thorens B; Geering K; Horisberger JD; Bonny O
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F612-9. PubMed ID: 19587147
[TBL] [Abstract][Full Text] [Related]
13. Nuciferine restores potassium oxonate-induced hyperuricemia and kidney inflammation in mice.
Wang MX; Liu YL; Yang Y; Zhang DM; Kong LD
Eur J Pharmacol; 2015 Jan; 747():59-70. PubMed ID: 25499818
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamics of hyperuricemia.
Sánchez-Lozada LG; Tapia E; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
Semin Nephrol; 2005 Jan; 25(1):19-24. PubMed ID: 15660330
[TBL] [Abstract][Full Text] [Related]
15. Mulberroside a possesses potent uricosuric and nephroprotective effects in hyperuricemic mice.
Wang CP; Wang Y; Wang X; Zhang X; Ye JF; Hu LS; Kong LD
Planta Med; 2011 May; 77(8):786-94. PubMed ID: 21154198
[TBL] [Abstract][Full Text] [Related]
16. Purine Metabolic Pathway Alterations and Serum Urate Changes after Oral Inosine Loading in Male Chinese Volunteers.
Liang N; Wu M; Gao Y; Yang S; Lin X; Sun H; Liang N; Yin H; Qu S; Chen H
Mol Nutr Food Res; 2024 Jan; 68(2):e2300115. PubMed ID: 38039425
[TBL] [Abstract][Full Text] [Related]
17. Hyperuricemia, gout and the kidney.
Gibson T
Curr Opin Rheumatol; 2012 Mar; 24(2):127-31. PubMed ID: 22157498
[TBL] [Abstract][Full Text] [Related]
18. Mouse models for human hyperuricaemia: a critical review.
Lu J; Dalbeth N; Yin H; Li C; Merriman TR; Wei WH
Nat Rev Rheumatol; 2019 Jul; 15(7):413-426. PubMed ID: 31118497
[TBL] [Abstract][Full Text] [Related]
19. Effects of elevated serum urate on cardiometabolic and kidney function markers in a randomised clinical trial of inosine supplementation.
Dalbeth N; Mihov B; Stewart A; Gamble GD; Merriman TR; Mount D; Reid IR; Stamp LK; Horne A
Sci Rep; 2022 Jul; 12(1):12887. PubMed ID: 35902652
[TBL] [Abstract][Full Text] [Related]
20. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats.
Sánchez-Lozada LG; Tapia E; Santamaría J; Avila-Casado C; Soto V; Nepomuceno T; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
Kidney Int; 2005 Jan; 67(1):237-47. PubMed ID: 15610247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
